Rezlidhia

Generic name: Olutasidenib
Dosage form: capsules
Drug class: Miscellaneous antineoplastics

Usage of Rezlidhia

Rezlidhia is a prescription medicine used to treat adults with acute myeloid leukemia (AML) with a specific gene mutation called IDH1. 

The IDH1 mutation prevents immature blood cells in the bone marrow from developing into healthy mature blood cells.

Rezlidhia contains olutasidenib, which belongs to the class of drugs called isocitrate dehydrogenase-1 (IDH1) inhibitors. It works to treat acute myeloid leukemia by blocking the activity of the protein produced by IDH1.

Your healthcare provider will test you for the IDH1 mutation with an FDA-approved test to make sure that Rezlidhia is right for you.

It is not known if this medicine is safe and effective in children.

Rezlidhia side effects

Rezlidhia may cause serious side effects, including:

  • See Important information
  • Liver problems. Changes in liver function tests are common during treatment with Rezlidhia and can be serious. Your healthcare provider will do blood tests to check your liver function before and during treatment. Tell your healthcare provider right away if you develop any of the following symptoms of liver problems during treatment:
  • yellowing of your skin or the white part of your eyes (jaundice)
  • dark "tea-colored" urine
  • loss of appetite
  • pain on the upper right side of your stomach area
  • feeling very tired or weak

    • The most common side effects include:

  • abnormal liver function tests
  • nausea
  • feeling tired or unwell
  • joint pain
  • constipation
  • shortness of breath
  • fever
  • rash
  • mouth sores
  • diarrhea
  • changes in certain blood tests

    • Tell your healthcare provider if you have any nausea, constipation, diarrhea, vomiting, stomach pain or mouth sores.

    Your healthcare provider will do blood tests before you start, and during treatment. Your healthcare provider may decrease, temporarily hold, or permanently stop your treatment if you develop certain side effects.

    These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    Before taking Rezlidhia

    Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • are pregnant or plan to become pregnant. Rezlidhia may harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Rezlidhia passes into your breast milk. Do not breastfeed during your treatment, and for 2 weeks after your last dose.

    • Relate drugs

    How to use Rezlidhia

    Usual Adult Dose for Acute Myeloid Leukemia

    150 mg orally twice daily, until disease progression or unacceptable toxicity.

    Comments: -Select patients based on presence of IDH1 mutation(s). -Take on an empty stomach at least 1 hour before or 2 hours after a meal.

    Use: -Treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test. 

    Warnings

    Rezlidhia may cause serious side effects including:

    Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells and may be lifethreatening or lead to death. Differentiation syndrome in adults with acute myeloid leukemia (AML) has occurred as early as 1 day and up to 18 months after starting Rezlidhia. Call your healthcare provider or go to the nearest hospital emergency room right away if you develop any of the following symptoms of differentiation syndrome during treatment:

  • fever
  • cough
  • trouble breathing
  • decreased urination
  • dizziness or lightheadedness
  • weight gain
  • swelling of your arms or legs 

    • If you develop signs and symptoms of differentiation syndrome, your healthcare provider may treat you with a corticosteroid medicine or a medicine called hydroxyurea and may monitor you in the hospital.

    See Rezlidhia side effects for more information about side effects.

    What other drugs will affect Rezlidhia

    Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

    Especially tell your doctor if you take:

  • medicines for epilepsy (phenobarbital, Carbamazepine, eslicarbazepine, cenobamate, fosphenytoin, oxcarbazepine, phenytoin, primidone);
  • medicines containing rifampin;
  • medicines containing rifabutin;
  • apalutamide, enzalutamide;
  • bosentan;
  • bexarotene;
  • HIV medicines containing efavirenz, etravirine, or nevirapine;
  • lorlatinib
  • medicines containing elagolix
  • medicines containing lumacaftor;
  • modafinil, armodafinil;
  • nafcillin
  • St. John's wort

    • Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist each time you get a new medicine.

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords